@article{90afd4d6c3f547669d08d30e9cdef6fb,
title = "Abstract 4413: A 5-gene model predicts clinical outcome in ER+/PR+, early stage breast cancers treated with adjuvant tamoxifen",
author = "Kerr, \{Daniel Alan\} and Wittliff, \{James L.\}",
note = "Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Purpose: Patients with primary breast carcinomas expressing of both estrogen (ERα) and progesterone receptors (PR) are more likely to respond to Tamoxifen therapy than those with ERα and PR negative cancers, especially in women with early stage lesions.",
year = "2011",
month = apr,
day = "15",
doi = "10.1158/1538-7445.AM2011-4413",
language = "American English",
volume = "71",
journal = "Cancer Research",
issn = "1538-7445",
publisher = "American Association for Cancer Research",
}